News24 | Talks have started to get the twice-yearly anti-HIV jab registered in SA

Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss how to get the shot registered locally as fast as possible in the country. Sahpra will have to work with the European Medicines Agency on this, as it’s severely understaffed and unable to review medicines speedily.